501 related articles for article (PubMed ID: 11714700)
1. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
Hoffman WH; Biade S; Zilfou JT; Chen J; Murphy M
J Biol Chem; 2002 Feb; 277(5):3247-57. PubMed ID: 11714700
[TBL] [Abstract][Full Text] [Related]
2. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
3. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
4. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.
Lee SJ; Ha MJ; Lee J; Nguyen P; Choi YH; Pirnia F; Kang WK; Wang XF; Kim SJ; Trepel JB
J Biol Chem; 1998 Apr; 273(17):10618-23. PubMed ID: 9553123
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
7. Aberrant regulation of survivin by the RB/E2F family of proteins.
Jiang Y; Saavedra HI; Holloway MP; Leone G; Altura RA
J Biol Chem; 2004 Sep; 279(39):40511-20. PubMed ID: 15271987
[TBL] [Abstract][Full Text] [Related]
8. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
9. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
11. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells.
Kuo PC; Liu HF; Chao JI
J Biol Chem; 2004 Dec; 279(53):55875-85. PubMed ID: 15456784
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
13. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
[TBL] [Abstract][Full Text] [Related]
14. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
15. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
16. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
17. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
18. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
19. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
Koziczak M; Müller H; Helin K; Nagamine Y
Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]